Xerostomia is defined as the “complaint of oral dryness”. It can occur due to inadequate salivary secretion secondary to abnormal function of the salivary glands, which is categorized as “true” xerostomia; however, most patients with xerostomia often do not have objective signs of hypo salivation. “Symptomatic” xerostomia or “pseudo” xerostomia refers to oral dryness despite normal salivary gland function.
DelveInsight’s “Xerostomia Market Insights, Epidemiology, and Market Forecast-2030″ report delivers an in-depth understanding of the Xerostomia, historical and forecasted epidemiology as well as the Xerostomia market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
The Xerostomia market report provides current treatment practices, emerging drugs, Xerostomia market share of the individual therapies, current and forecasted Xerostomia market Size from 2017 to 2030 segmented by seven major markets. The Report also covers current Xerostomia treatment practice/algorithm, market drivers, market barriers and unmet medical needs to curate best of the opportunities and assesses the underlying potential of the market.
Get Free Sample Copy of Report at: https://www.delveinsight.com/sample-request/xerostomia-market
Some of the Xerostomia Facts are:
Some of Xerostomia Companies involved:
Xerostomia therapies Covered:
The causes of xerostomia may be divided into two broad categories: systemic diseases and local factors. Systemic diseases that can cause xerostomia include, but are not limited to, endocrine, autoimmune, infectious, and granulomatous diseases. The more common systemic diseases are reviewed here. Local factors that can cause xerostomia include medications, head and neck radiation therapy, and lifestyle factors.
Table of Contents:
1. Key Insights
2. Executive Summary of Xerostomia
3. Competitive Intelligence Analysis for Xerostomia
4. Xerostomia: Market Overview at a Glance
5. Xerostomia: Disease Background and Overview
6. Patient Journey
7. Xerostomia Epidemiology and Patient Population
8. Treatment Algorithm, Current Treatment, and Medical Practices
9. Unmet Needs
10. Key Endpoints of Xerostomia Treatment
11. Marketed Products
12. Emerging Therapies
13. Xerostomia: Seven Major Market Analysis
14. Attribute analysis
15. 7MM: Market Outlook
16. Access and Reimbursement Overview of Xerostomia
17. KOL Views
18. Market Drivers
19. Market Barriers
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer
23. About DelveInsight
About DelveInsight DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end-to-end comprehensive solutions to improve their performance.
Media ContactCompany Name: DelveInsight Business Research LLPContact Person: Ankit NigamEmail: Send EmailPhone: +19193216187Address:304 S. Jones Blvd #2432 City: AlbanyState: New YorkCountry: United StatesWebsite: https://www.delveinsight.com/report-store/xerostomia-market